Active immunization against Pneumocystis carinii with p55-v3 DNA vaccine in rats

Canadian Journal of Microbiology

Volumn 57, Issue 5, 2011, Pages 375-381

  Feng, Yanmei ^a   Guo, Shuliang ^a   Jiang, Tao ^a   Han, Xiaoli ^a   Liu, Ping ^a   Wu, Tingting ^a   Luo, Yongai ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

DNA vaccine; P55 v3; Pneumocystis carinii; Rat

Indexed keywords

ALTERNATIVE APPROACH; BODY WEIGHT; DNA VACCINE; EPITOPE MAPPING; HUMORAL IMMUNITY; P55-V3; PCP MODELS; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIAS;

ANTIGENS; CHEMOTHERAPY; DNA; GENES; IMMUNIZATION; RATS;

VACCINES;

DNA VACCINE; P55 V3 DNA VACCINE; UNCLASSIFIED DRUG;

BODY MASS; CHEMOTHERAPY; FUNGAL DISEASE; FUNGUS; GENE; HISTOLOGY; IMMUNITY; IMMUNIZATION; PNEUMONIA; RODENT; VACCINATION; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELLULAR IMMUNITY; CLINICAL EVALUATION; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNIZATION; LUNG WEIGHT; MEDICAL RECORD; NONHUMAN; PATHOGEN LOAD; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROTECTION; RAT; VACCINATION;

ANIMALS; ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOKINES; FEMALE; FUNGAL PROTEINS; FUNGAL VACCINES; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; LYMPHOCYTE ACTIVATION; PNEUMOCYSTIS CARINII; PNEUMONIA, PNEUMOCYSTIS; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN; T-LYMPHOCYTES; VACCINATION; VACCINES, DNA;

PNEUMOCYSTIS; PNEUMOCYSTIS CARINII; RATTUS;

EID: 80052288511     PISSN: 00084166     EISSN: 14803275     Source Type: Journal    
DOI: 10.1139/w11-023     Document Type: Article

References (29)

1. Bartlett, M.S., Angus, W.C., Shaw, M.M., Durant, P.J., Lee, C.H., Pascale, J.M., and Smith, J.W. 1998. Antibody to Pneumocystis carinii protects rats and mice from developing pneumonia. Clin. Diagn. Lab. Immunol. 5(1): 74-77. PMID:9455884.
2. Boehm, U., Klamp, T., Groot, M., and Howard, J.C. 1997. Cellular responses to interferon-g. Annu. Rev. Immunol. 15(1): 749-795. doi:10.1146/annurev.immunol.15.1.749. PMID:9143706.
3. Cattamanchi, A., Posavad, C.M., Wald, A., Baine, Y., Moses, J., Higgins, T.J., et al. 2008. Phase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2-seronegative adults by a needle-free injection system. Clin. Vaccine Immunol. 15(11): 1638-1643. doi:10.1128/CVI.00167-08. PMID:18784341.
4. Curtis, J.L. 2005. Cell-mediated adaptive immune defense of the lungs. Proc. Am. Thorac. Soc. 2(5): 412-416. doi:10.1513/pats. 200507-070JS. PMID:16322591.
5. Enosse, S., Dobano, C., Quelhas, D., Aponte, J.J., Lievens, M., Leach, A., et al. 2006. RTS, S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection. PLoS Clin. Trials, 1(1): e5. doi:10. 1371/journal.pctr.0010005. PMID:16871327.
6. Ferreira, D.M., Oliveira, M.L., Moreno, A.T., Ho, P.L., Briles, D.E., and Miyaji, E.N. 2010. Protection against nasal colonization with Streptococcus pneumoniae by parenteral immunization with a DNA vaccine encoding PspA (Pneumococcal surface protein A). Microb. Pathog. 48(6): 205-213. doi:10.1016/j.micpath.2010.02. 009. PMID:20206678.
7. Garvy, B.A., Wiley, J.A., Gigliotti, F., and Harmsen, A.G. 1997. Protection against Pneumocystis carinii pneumonia by antibodies generated from either T helper 1 or T helper 2 responses. Infect. Immun. 65(12): 5052-5056. PMID:9393795.
8. Gigliotti, F., Haidaris, C.G., Wright, T.W., and Harmsen, A.G. 2002. Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia. Infect. Immun. 70(3): 1069-1074. doi:10.1128/IAI.70.3.1069-1074.2002. PMID:11854184.
9. Huang, L., Crothers, K., Atzori, C., Benfield, T., Miller, R., Rabodonirina, M., and Helweg-Larsen, J. 2004. Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance. Emerg. Infect. Dis. 10(10): 1721-1728. PMID:15504256.
10. Keely, S.P., Linke, M.J., Cushion, M.T., and Stringer, J.R. 2007. Pneumocystis murina MSG gene family and the structure of the locus associated with its transcription. Fungal Genet. Biol. 44(9): 905-919. doi:10.1016/j.fgb.2007.01.004. PMID:17320432.
11. Kelly, M.N., and Shellito, J.E. 2010. Current understanding of Pneumocystis immunology. Future Microbiol. 5(1): 43-65. doi:10. 2217/fmb.09.116. PMID:20020829.
12. Kim, C.K., Foy, J.M., Cushion, M.T., Stanforth, D., Linke, M.J., Hendrix, H.L., and Walzer, P.D. 1987. Comparison of histologic and quantitative techniques in evaluation of therapy for experimental Pneumocystis carinii pneumonia. Antimicrob. Agents Chemother. 31(2): 197-201. PMID:3494426.
13. Kling, H.M., Shipley, T.W., Patil, S., Morris, A., and Norris, K.A. 2009. Pneumocystis colonization in immunocompetent and simian immunodeficiency virus-infected cynomolgus macaques. J. Infect. Dis. 199(1): 89-96. doi:10.1086/595297. PMID:19014344.
14. Kutty, G., Maldarelli, F., Achaz, G., and Kovacs, J.A. 2008. Variation in the major surface glycoprotein genes in Pneumocystis jirovecii. J. Infect. Dis. 198(5): 741-749. doi:10.1086/590433. PMID: 18627244.
15. Luxembourg, A., Hannaman, D., Wills, K., Bernard, R., Tennant, B. C., Menne, S., and Cote, P.J. 2008. Immunogenicity in mice and rabbits of DNA vaccines expressing woodchuck hepatitis virus antigens. Vaccine, 26(32): 4025-4033. doi:10.1016/j.vaccine. 2008.05.021. PMID:18556096.
16. Ma, L., Kutty, G., Jia, Q., and Kovacs, J.A. 2003. Characterization of variants of the gene encoding the p55 antigen in Pneumocystis from rats and mice. J. Med. Microbiol. 52(11): 955-960. doi:10. 1099/jmm.0.05131-0. PMID:14532339.
17. Rosati, M., Valentin, A., Jalah, R., Patel, V., von Gegerfelt, A., Bergamaschi, C., et al. 2008. Increased immune responses in rhesus macaques by DNA vaccination combined with electroporation. Vaccine, 26(40): 5223-5229. doi:10.1016/j.vaccine.2008.03. 090. PMID:18468743.
18. Sharma, D.P., Ramsay, A.J., Maguire, D.J., Rolph, M.S., and Ramshaw, I.A. 1996. Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo. J. Virol. 70(10): 7103-7107. PMID:8794356.
19. Smulian, A.G., Stringer, J.R., Linke, M.J., and Walzer, P.D. 1992. Isolation and characterization of a recombinant antigen of Pneumocystis carinii. Infect. Immun. 60(3): 907-915. PMID:1541564.
20. Smulian, A.G., Theus, S.A., Denko, N., Walzer, P.D., and Stringer, J. R. 1993. A 55 kDa antigen of Pneumocystis carinii: analysis of the cellular immune response and characterization of the gene. Mol. Microbiol. 7(5): 745-753. doi:10.1111/j.1365-2958.1993. tb01165.x. PMID:8469116.
21. Smulian, A.G., Sullivan, D.W., and Theus, S.A. 2000. Immunization with recombinant Pneumocystis carinii p55 antigen provides partial protection against infection: characterization of epitope recognition associated with immunization. Microbes Infect. 2(2): 127-136. doi:10.1016/S1286-4579(00)00275-6. PMID:10742685.
22. Theus, S.A., Sullivan, D.W., Walzer, P.D., and Smulian, A.G. 1994. Cellular responses to a 55-kilodalton recombinant Pneumocystis carinii antigen. Infect. Immun. 62(8): 3479-3484. PMID:8039919.
23. Theus, S.A., Andrews, R.P., Linke, M.J., and Walzer, P.D. 1997. Characterization of rat CD4 T cell clones specific for the major surface glycoprotein of Pneumocystis carinii. J. Eukaryot. Microbiol. 44(2): 96-100. doi:10.1111/j.1550-7408.1997. tb05944.x. PMID:9109259.
24. Theus, S.A., Smulian, A.G., Steele, P., Linke, M.J., and Walzer, P.D. 1998. Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response. Vaccine, 16(11-12): 1149-1157. doi:10.1016/S0264-410X(98)80113-8. PMID:9682373.
25. Walzer, P.D., Stanforth, D., Linke, M.J., and Cushion, M.T. 1987. Pneumocystis carinii: immunoblotting and immunofluorescent analyses of serum antibodies during experimental rat infection and recovery. Exp. Parasitol. 63(3): 319-328. doi:10.1016/0014-4894 (87)90179-2. PMID:3556208.
26. Wells, J., Haidaris, C.G., Wright, T.W., and Gigliotti, F. 2006. Active immunization against Pneumocystis carinii with a recombinant P. carinii antigen. Infect. Immun. 74(4): 2446-2448. doi:10.1128/ IAI.74.4.2446-2448.2006. PMID:16552076.
27. Zhang, W., Ahmad, G., Torben, W., and Siddiqui, A.A. 2010. Smp80-based DNA vaccine made in a human use approved vector VR1020 protects against challenge infection with Schistosoma mansoni in mouse. Parasite Immunol. 32(4): 252-258. doi:10. 1111/j.1365-3024.2009.01181.x. PMID:20398225.
28. + T cell-independent vaccination against Pneumocystis carinii in mice. J. Clin. Invest. 108(10): 1469-1474. PMID: 11714738.
29. Zheng, M., Ramsay, A.J., Robichaux, M.B., Norris, K.A., Kliment, C., Crowe, C., et al. 2005. CD4+ T cell-independent DNA vaccination against opportunistic infections. J. Clin. Invest. 115(12): 3536-3544. doi:10.1172/JCI26306. PMID:16308571.